{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:00:22Z","timestamp":1760547622190},"reference-count":0,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":4268,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Autonomic Pharmacology"],"published-print":{"date-parts":[[1997,2]]},"abstract":"<jats:p> <jats:bold>1<\/jats:bold>\u2003Contractile responses of smooth muscle from the Wistar rat urinary bladder were studied with the use of muscarinic agonists and antagonists.<\/jats:p><jats:p> <jats:bold>2\u2003<\/jats:bold>McN\u2010A\u2010343 induced only weak contractile responses of the bladder muscle. In contrast, oxotremorine showed higher potency than either acetylcholine or bethanechol in inducing a contractile response (the respective p<jats:italic>D<\/jats:italic><jats:sub>2<\/jats:sub> values were 6.38\u2003\u00b1\u20030.25, 4.82\u2003\u00b1\u20030.24 and 4.42\u2003\u00b1\u20030.14).<\/jats:p><jats:p> <jats:bold>3\u2003<\/jats:bold>The M<jats:sub>2<\/jats:sub> antagonists, methoctramine (10<jats:sup>\u22129<\/jats:sup><jats:sc>m<\/jats:sc> to 10<jats:sup>\u22125<\/jats:sup><jats:sc>m<\/jats:sc>) and gallamine (10<jats:sup>\u22129<\/jats:sup><jats:sc>m<\/jats:sc> to 10<jats:sup>\u22125<\/jats:sup><jats:sc>m<\/jats:sc>), did not reduce acetylcholine\u2010induced (10<jats:sup>\u22125<\/jats:sup><jats:sc>m<\/jats:sc>) contractions of the bladder muscle strip. On the other hand, 4\u2010diphenyl\u2010acetoxy\u2010<jats:italic>N<\/jats:italic>\u2010methyl piperidine methiodide (4\u2010DAMP, 10<jats:sup>\u221210<\/jats:sup><jats:sc>m<\/jats:sc> to 10<jats:sup>\u22127<\/jats:sup><jats:sc>m<\/jats:sc>), an M<jats:sub>3<\/jats:sub> receptor blocker, effectively antagonized the acetylcholine\u2010induced contractions in a concentration\u2010dependent manner. 4\u2010DAMP had a similar p<jats:italic>A<\/jats:italic><jats:sub>2<\/jats:sub> value to those of the non\u2010selective antagonists, atropine and scopolamine (p<jats:italic>A<\/jats:italic><jats:sub>2<\/jats:sub> values were 8.26\u2003\u00b1\u20030.05, 8.36\u2003\u00b1\u20030.05 and 8.41\u2003\u00b1\u20030.11, respectively). Pirenzepine, an M<jats:sub>1<\/jats:sub> blocker, antagonized the contractions at higher concentrations (10<jats:sup>\u22128<\/jats:sup><jats:sc>m<\/jats:sc> to 10<jats:sup>\u22125<\/jats:sup><jats:sc>m<\/jats:sc>, p<jats:italic>A<\/jats:italic><jats:sub>2<\/jats:sub>= 6.23\u2003\u00b1\u20030.04).<\/jats:p><jats:p> <jats:bold>4\u2003<\/jats:bold>It is concluded that (1) the dominant muscarinic receptor subtype responsible for smooth muscle contraction in the rat urinary bladder is M<jats:sub>3<\/jats:sub>; and (2) the muscarinic agonist oxotremorine was more potent than acetylcholine and bethanechol in inducing a contractile response.<\/jats:p>","DOI":"10.1046\/j.1365-2680.1997.00436.x","type":"journal-article","created":{"date-parts":[[2003,11,27]],"date-time":"2003-11-27T11:00:08Z","timestamp":1069930808000},"page":"21-25","source":"Crossref","is-referenced-by-count":25,"title":["Pharmacological characterization of the muscarinic receptor subtypes responsible for the contractile response in the rat urinary bladder"],"prefix":"10.1111","volume":"17","author":[{"given":"Y.\u2010C.","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.\u2010C.","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.\u2010N.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.\u2010T.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"container-title":["Journal of Autonomic Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2680.1997.00436.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2680.1997.00436.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T05:27:36Z","timestamp":1698470856000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2680.1997.00436.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1046\/j.1365-2680.1997.00436.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2680.1997.00436.x","archive":["Portico"],"relation":{},"ISSN":["0144-1795","1365-2680"],"issn-type":[{"value":"0144-1795","type":"print"},{"value":"1365-2680","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}